Catechol-O-methyltransferase gene polymorphism is associated with skeletal muscle properties in older women alone and together with physical activity

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Ronkainen, Paula H A ^a   Pöllänen, Eija ^a   Törmäkangas, Timo ^a   Tiainen, Kristina ^a   Koskenvuo, Markku ^b   Kaprio, Jaakko ^c,d   Rantanen, Taina ^a   Sipilä, Sarianna ^a   Kovanen, Vuokko ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; ESTROGEN; ESTROGEN RECEPTOR; METHIONINE; VALINE;

ADULT; AGE; AGED; AGING; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ESTROGEN SYNTHESIS; FEMALE; GENOTYPE; HAND GRIP; HEIGHT; HEREDITY; HUMAN; HUMAN EXPERIMENT; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL ACTIVITY; POSTMENOPAUSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SITTING; SKELETAL MUSCLE; ENZYMOLOGY; EXERCISE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PHYSIOLOGY; TWINS;

AGED; CATECHOL O-METHYLTRANSFERASE; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; MUSCLE, SKELETAL; POLYMORPHISM, GENETIC;

EID: 46649102059     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001819     Document Type: Article

References (56)

1. Nader CA (2005) Molecular determinants of skeletal muscle mass: Getting the "AKT" together. Int J Biochem Cell Biol 37: 1985-1996.
2. Zurlo F, Larson K, Bogardus C, Ravussin E (1990) Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86: 1423-1427.
3. Harridge SD (2007) Plasticity of human skeletal muscle: Gene expression to in vivo function. Exp Physiol 92: 783-797.
4. Rantanen T, Masaki K, Foley D, Izmirlian G, White L, et al. (1998) Grip strength changes over 27 yr in japanese-american men. J Appl Physiol 85: 2047-2053.
5. Doherty TJ (2003) Invited review: Aging and sarcopenia. J Appl Physiol 95: 1717-1727.
6. Greenlund LJ, Nair KS (2003) Sarcopenia-consequences, mechanisms, and potential therapies. Mech Ageing Dev 124: 287-299.
7. Roubenoff R, Castaneda C (2001) Sarcopenia-understanding the dynamics of aging muscle. JAMA 286: 1230-1231.
8. Beunen G, Thomis M (2004) Gene powered? where to go from heritability (h2) in muscle strength and power? Exerc Sport Sci Rev 32: 148-154.
9. Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, et al. (2005) Shared genetic and environmental effects on strength and power in older female twins. Med Sci Sports Exerc 37: 72-78.
10. Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, et al. (2004) Heritability of maximal isometric muscle strength in older female twins. J Appl Physiol 96: 173-180.
11. Loos R, Thomis M, Maes HH, Beunen G, Claessens AL, et al. (1997) Gender-specific regional changes in genetic structure of muscularity in early adolescence. J Appl Physiol 82: 1802-1810.
12. Thomis MA, Van Leemputte M, Maes HH, Blimkie CJ, Claessens AL, et al. (1997) Multivariate genetic analysis of maximal isometric muscle force at different elbow angles. J Appl Physiol 82: 959-967.
13. Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 84: 95-98.
14. Samson MM, Meeuwsen IB, Crowe A, Dessens JA, Duursma SA, et al. (2000) Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 29: 235-242.
15. Sipila S, Taaffe DR, Cheng S, Puolakka J, Toivanen J, et al. (2001) Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: A randomized placebo-controlled study. Clin Sci (Lond) 101: 147-157.
16. Taaffe DR, Sipila S, Cheng S, Puolakka J, Toivarien J, et al. (2005) The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: A yearlong intervention. Clin Physiol Funct Imaging 25: 297-304.
17. Skelton DA, Phillips SK, Bruce SA, Naylor CH, Woledge RC (1999) Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci (Lond) 96: 357-364.
18. Dobs AS, Nguyen T, Pace C, Roberts CP (2002) Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 87: 1509-1516.
19. Kenny AM, Kleppinger A, Wang Y, Prestwood KM (2005) Effects of ultra-low-dose estrogen therapy on muscle and physical function in older women. J Am Geriatr Soc 53: 1973-1977.
20. Ribom EL, Piehl-Aulin K, Ljunghall S, Ljunggren O, Naessen T (2002) Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women. Maturitas 42: 225-231.
21. Tanko LB, Movsesyan L, Svendsen OL, Christiansen C (2002) The effect of hormone replacement therapy on apprendicular lean tissue mass in early postmenopausal women. Menopause 9: 117-121.
22. Puah JA, Bailey CJ (1985) Effect of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinology 117: 1336-1340.
23. Rance NE, Max SR (1984) Modulation of the cytosolic androgen receptor in striated muscle by sex steroids. Endocrinology 115: 862-866.
24. Zhu BT, Cooney AH (1998) Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 19: 1-27.
25. Dcroo BJ, Korach KS (2006) Estrogen receptors and human disease. J Clin Invest 116: 561-570.
26. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, et al. (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202-4210.
27. Scanlon PD, Raymond FA, Weinshilboum RM (1979) Catechol-O-methyl-transferase: Thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 203: 63-65.
28. Mannisto PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51: 593-628.
29. Lorentzen M, Eriksson AL, Mellstrom D, Ohlsson C (2004) The COMT vall 58met polymorphism is associated with peak BMD in men. J Bone Miner Res 19: 2005-2011.
30. Stolk L, van Meurs JB, Jhamai M, Arp PP, van Leeuwen JP, et al. (2007) The catechol-O-methyltramferase Met158 "low activity" allele and association with non-vertebral fracture risk in elderly men. J Clin Endocrinol Metab.
31. Eriksson AL, Suuriniemi M, Mahonen A, Cheng S, Ohlsson C (2005) The COMT vall58met polymorphism is associated with early pubertal development, height and cortical bone mass in girls. Pediatr Res 58: 71-77.
32. Lurie G, Maskarinec G, Kaaks R, Stanczyk FZ, Le Marchand L (2005) Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 14: 1521-1627.
33. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, et al. (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96: 936-945.
34. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, et al. (2004) Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serun and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13: 94-101.
35. Worda. C, Sator MO, Schneeberger C, Jantschev T, Ferlitsch K, et al. (2003) Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 18: 262-266.
36. Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML, et al. (2003) Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc 35: 439-443.
37. Castagnoli A, Maestri I, Bernardi F, Del Senno L (1987) PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15: 866.
38. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, et al. (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105: 1879-1882.
39. Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, et al. (1999) Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. J Bone Miner Res 14: 1576-1582.
40. Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, et al. (2002) Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women. Ann Med 34: 64-72.
41. Kaprio J, Pulkkinen L, Rose RJ (2002) Genetic and environmental factors in health-related behaviors: Studies on finnish twins and twin families. Twin Res 5: 366-371.
42. Kaprio J, Sarna S, Koskenvuo M, Rantasalo I (1978) The finnish twin registry: Formation and compilation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res 24 Pt B. pp 179-184.
43. Bjornerem A, Straume B, Midtby M, Fonnebo V, Sundsfjord J, et al. (2004) Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: The tromso study. J Clin Endocrinol Metab 89: 6039-6047.
44. Sodergard R, Backstrom T, Shanbhag V, Carstensen H (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16: 801-810.
45. Sipila S, Multanen J, Kallinen M, Era P, Suominen H (1996) Effects of strength and endurance training on isometric muscle strength and walking speed in elderly women. Acta Physiol Scand 156: 457-464.
46. Rantanen T, Era P, Kauppinen M, Heikkinen E (1994) Maximal isometric muscle strength and socio-economic status, health and physical activity in 75-year-old persons. J Aging Phys Activity 2: 206-220.
47. Fujita Y, Nakamura Y, Hiraoka J, Kobayashi K, Sakata K, et al. (1995) Physical-strength tests and mortality among visitors to health-promotion centers in japan. J Clin Epidemiol 48: 1349-1359.
48. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, et al. (1999) Midlife hand grip strength as a predictor of old age disability. JAMA 281: 558-560.
49. Rantanen T, Guralnik JM, Ferrucci L, Penninx BW, Leveille S, et al. (2001) Coimpairments as predictors of severe walking disability in older women. J Am Geriatr Soc 49: 21-27.
50. Bassey EJ, Short AH (1990) A new method for measuring power output in a single leg extension: Feasibility, reliability and validity. Eur J Appl Physiol Occup Physiol 60: 385-390.
51. Rantanen T, Era P, Heikkinen E (1997) Physical activity and the changes in maximal isometric strength in men and women from the age of 75 to 80 years. J Am Geriatr Soc 45: 1439-1445.
52. Grimby G (1986) Physical activity and muscle training in the elderly. Acta Med Scand Suppl 711: 233-237.
53. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250.
54. Al-Hendy A, Salama SA (2006) Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 13: 136-144.
55. Natarajan S, Lipsitz S, Parzen M, Lipshultz S (2007) A measure of partial association for generalized estimating equations. Statistical modelling 7: 175-190.
56. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, et al. (2006) Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 91: 3791-3797.